Skip to main content

Table 3 Improvement in all-cause mortality risk prediction by adding NT-ProBNP to clinical models across the BMI categories

From: Association of N-terminal pro-B-type natriuretic peptide levels and mortality risk in acute myocardial infarction across body mass index categories: an observational cohort study

Clinical models

C-Statistics [95% CI]

â–³ in C-Statistics

P Value

NRI [95% CI]

IDI [95% CI]

BMI < 18.5 kg/m2

 Long-term GRACE risk score

0.709 [0.637–0.781]

Reference

Reference

Reference

Reference

 NT-proBNP

0.722 [0.652–0.793]

0.014

0.710

0.062 [− 0.236–0.364]

− 0.010 [− 0.149–0.153]

 Long-term GRACE risk score + NT-proBNP

0.747 [0.679–0.815]

0.038

0.124

0.270 [− 0.049–0.496]

0.066 [− 0.011–0.175]

BMI 18.5–23.9 kg/m2

 Long-term GRACE risk score

0.757 [0.727–0.786]

Reference

Reference

Reference

Reference

 NT-proBNP

0.764 [0.735–0.794]

0.008

0.624

− 0.022 [− 0.135–0.112]

− 0.002 [− 0.058–0.057]

 Long-term GRACE risk score + NT-proBNP

0.793 [0.765–0.821]

0.036

 < 0.001

0.263 [0.177–0.358]

0.076 [0.043–0.116]

BMI 24–27.9 kg/m2

 Long-term GRACE risk score

0.807 [0.780–0.835]

Reference

Reference

Reference

Reference

 NT-proBNP

0.808 [0.781–0.835]

0.001

0.949

− 0.072 [− 0.178–0.040]

− 0.036 [− 0.096–0.024]

 Long-term GRACE risk score + NT-proBNP

0.849 [0.827–0.871]

0.042

 < 0.001

0.204 [0.092–0.284]

0.046 [0.019–0.079]

BMI ≥ 28 kg/m2

 Long-term GRACE risk score

0.800 [0.752–0.847]

Reference

Reference

Reference

Reference

 NT-proBNP

0.790 [0.748–0.832]

− 0.010

0.703

− 0.158 [− 0.316–0.032]

− 0.077 [− 0.156–− 0.002]

 Long-term GRACE risk score + NT-proBNP

0.832 [0.791–0.872]

0.032

0.012

0.197 [0.063–0.340]

0.023 [0.000–0.065]

  1. △ = difference
  2. BMI, body mass index; CI, confidence interval; GRACE, Global Registry of Acute Coronary Events; IDI, integrated discrimination improvement; NRI, net reclassification index; NT-proBNP, N-terminal pro-B-type natriuretic peptide